INMUNE BIO INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INMUNE BIO INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $22.27M, a 996.01% increase year-over-year.
- INMUNE BIO INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $5.27M.
- INMUNE BIO INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $2.03M.
- INMUNE BIO INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $775.00K.
- INMUNE BIO INC. stock issued during period, value, new issues for fiscal 2025 was $27.54M, a 1066.62% increase from fiscal 2024.
- INMUNE BIO INC. stock issued during period, value, new issues for fiscal 2024 was $2.36M, a 204.65% increase from fiscal 2023.
- INMUNE BIO INC. stock issued during period, value, new issues for fiscal 2023 was $775.00K, a 10.87% increase from fiscal 2022.
- INMUNE BIO INC. stock issued during period, value, new issues for fiscal 2022 was $699.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $27.54M 10-K · filed 2026-03-30 | |
| 2025-06-30 | $22.27M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $5.27M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $2.36M 10-K · filed 2026-03-30 | |
| 2024-06-30 | $2.03M 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $775.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $775.00K 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $699.00K 10-K · filed 2024-03-28 | |
| 2022-03-31 | $699.00K 10-Q · filed 2023-11-01 | |
| 2021-09-30 | $51.81M 10-Q · filed 2021-11-03 | |
| 2021-03-31 | $28.45M 10-Q · filed 2021-11-03 | |
| 2020-12-31 | $24.91M 10-K · filed 2021-03-04 | |
| 2020-09-30 | $23.24M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $664.00K 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $1.00M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $4.96M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $900.00K 10-K · filed 2020-03-11 | |
| 2018-03-31 | $900.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $2.06M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |